In the hunt for reverse merger targets, Caribou could be prized game

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 08 Oct, 15:23 UTC

The struggling cell therapy developer is exploring strategic alternatives, which, among other characteristics, make it a likely candidate to receive reverse merger interest.

science

Sources

• T2In the hunt for reverse merger targets, Caribou could be prized gameBioPharma Dive / Healthcare Dive / MedTech Dive08 Oct, 15:23